Jefferies analyst Brian Tanquilut reiterated a Buy rating and boosted his price target on Mednax (NYSE: MD) to $80.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE